Your browser doesn't support javascript.
loading
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.
Masuda, Norikazu; Bando, Hiroko; Yamanaka, Takashi; Kadoya, Takayuki; Takahashi, Masato; Nagai, Shigenori E; Ohtani, Shoichiro; Aruga, Tomoyuki; Suzuki, Eiji; Kikawa, Yuichiro; Yasojima, Hiroyuki; Kasai, Hiroi; Ishiguro, Hiroshi; Kawabata, Hidetaka; Morita, Satoshi; Haga, Hironori; Kataoka, Tatsuki R; Uozumi, Ryuji; Ohno, Shinji; Toi, Masakazu.
Affiliation
  • Masuda N; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuou-ku, Osaka, Japan. nmasuda@alpha.ocn.ne.jp.
  • Bando H; Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Yamanaka T; Breast and Endocrine Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Kadoya T; Department of Breast Surgery, Hiroshima University Hospital, Hiroshima University, Hiroshima, Japan.
  • Takahashi M; Department of Breast Surgery, NHO Hokkaido Cancer Center, Hokkaido, Japan.
  • Nagai SE; Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan.
  • Ohtani S; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Aruga T; Breast Surgery Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Suzuki E; Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kikawa Y; Department of Breast Surgery, Kobe City Medical Center General Hospital, Hyogo, Japan.
  • Yasojima H; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, 2-1-14 Hoenzaka, Chuou-ku, Osaka, Japan.
  • Kasai H; Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.
  • Ishiguro H; Breast Oncology Service, Saitama Medical University International Medical Center, Saitama, Japan.
  • Kawabata H; Department of Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
  • Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Haga H; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Kataoka TR; Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
  • Uozumi R; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ohno S; Breast Oncology Center, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
  • Toi M; Breast Cancer Unit, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Breast Cancer Res Treat ; 188(1): 117-131, 2021 Jul.
Article in En | MEDLINE | ID: mdl-33763789
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Breast Cancer Res Treat Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Breast Cancer Res Treat Year: 2021 Document type: Article Affiliation country: Country of publication: